| Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, ... Cell 182 (4), 812-827. e19, 2020 | 4534 | 2020 |
| Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection JM Dan, J Mateus, Y Kato, KM Hastie, ED Yu, CE Faliti, A Grifoni, ... Science 371 (6529), eabf4063, 2021 | 3114 | 2021 |
| Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity CR Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf, ... Cell 183 (4), 996-1012. e19, 2020 | 1969 | 2020 |
| Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design EO Saphire, PWHI Parren, R Pantophlet, MB Zwick, GM Morris, PM Rudd, ... science 293 (5532), 1155-1159, 2001 | 1156 | 2001 |
| Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41 MB Zwick, AF Labrijn, M Wang, C Spenlehauer, EO Saphire, JM Binley, ... Journal of virology 75 (22), 10892-10905, 2001 | 1039 | 2001 |
| Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor JE Lee, ML Fusco, AJ Hessell, WB Oswald, DR Burton, EO Saphire Nature 454 (7201), 177-182, 2008 | 889 | 2008 |
| The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→ 2 mannose residues on the outer face of gp120 CN Scanlan, R Pantophlet, MR Wormald, E Ollmann Saphire, R Stanfield, ... Journal of virology 76 (14), 7306-7321, 2002 | 866 | 2002 |
| Complement is activated by IgG hexamers assembled at the cell surface CA Diebolder, FJ Beurskens, RN De Jong, RI Koning, K Strumane, ... Science 343 (6176), 1260-1263, 2014 | 844 | 2014 |
| Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling WB Cárdenas, YM Loo, M Gale Jr, AL Hartman, CR Kimberlin, ... Journal of virology 80 (11), 5168-5178, 2006 | 577 | 2006 |
| gp120: Biologic aspects of structural features P Poignard, EO Saphire, PWHI Parren, DR Burton Annual review of immunology 19 (1), 253-274, 2001 | 380 | 2001 |
| Ebolavirus Glycoprotein Structure and Mechanism of Entry JE Lee, EO Saphire Future virology 4 (6), 621-635, 2009 | 374 | 2009 |
| Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression KM Hastie, CR Kimberlin, MA Zandonatti, IJ MacRae, EO Saphire Proceedings of the National Academy of Sciences 108 (6), 2396-2401, 2011 | 317 | 2011 |
| Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120 R Pantophlet, E Ollmann Saphire, P Poignard, PWHI Parren, IA Wilson, ... Journal of virology 77 (1), 642-658, 2003 | 314 | 2003 |
| Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study KM Hastie, H Li, D Bedinger, SL Schendel, SM Dennison, K Li, ... Science 374 (6566), 472-478, 2021 | 313 | 2021 |
| Contrasting IgG structures reveal extreme asymmetry and flexibility EO Saphire, RL Stanfield, MDM Crispin, PWHI Parren, PM Rudd, ... Journal of molecular biology 319 (1), 9-18, 2002 | 307 | 2002 |
| Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle ZA Bornholdt, T Noda, DM Abelson, P Halfmann, MR Wood, Y Kawaoka, ... Cell 154 (4), 763-774, 2013 | 276 | 2013 |
| Lassa fever in post-conflict Sierra Leone JG Shaffer, DS Grant, JS Schieffelin, ML Boisen, A Goba, JN Hartnett, ... PLoS neglected tropical diseases 8 (3), e2748, 2014 | 272 | 2014 |
| Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak ZA Bornholdt, HL Turner, CD Murin, W Li, D Sok, CA Souders, AE Piper, ... Science 351 (6277), 1078-1083, 2016 | 243 | 2016 |
| A role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus BM Gunn, WH Yu, MM Karim, JM Brannan, AS Herbert, AZ Wec, ... Cell host & microbe 24 (2), 221-233. e5, 2018 | 238 | 2018 |
| Structural basis for antibody-mediated neutralization of Lassa virus KM Hastie, MA Zandonatti, LM Kleinfelter, ML Heinrich, MM Rowland, ... Science 356 (6341), 923-928, 2017 | 226 | 2017 |
ParrenLeiden University Medical Center在 lumc.nl 的電子郵件地址已通過驗證
Zachary A BornholdtMapp Biopharmaceutical, Inc.在 mappbio.com 的電子郵件地址已通過驗證James CroweVanderbilt University Medical Center在 vanderbilt.edu 的電子郵件地址已通過驗證
Michael B. ZwickDepartment of Immunology and Microbiology, The Scripps Research Institute在 scripps.edu 的電子郵件地址已通過驗證
Kartik ChandranAlbert Einstein College of Medicine在 einsteinmed.edu 的電子郵件地址已通過驗證
Andrew FlyakCornell University在 cornell.edu 的電子郵件地址已通過驗證
M. Javad AmanPresident and Chief Scientific Officer, Integrated BioTherapeutics, Inc.在 integratedbiotherapeutics.com 的電子郵件地址已通過驗證
Hannah L TurnerThe Scripps Research Institute在 scripps.edu 的電子郵件地址已通過驗證
Benjamin DoranzIntegral Molecular在 integralmolecular.com 的電子郵件地址已通過驗證
Robert StahelinRetter Professor of Pharmacy, Purdue University在 purdue.edu 的電子郵件地址已通過驗證
Brandyn WestInvivyd Inc.在 invivyd.com 的電子郵件地址已通過驗證
Christoph A. DiebolderCharité - Universitätsmedizin Berlin在 charite.de 的電子郵件地址已通過驗證
Jessica BruhnSalk Institute for Biological Studies在 salk.edu 的電子郵件地址已通過驗證
Gene Garrard Olinger Jr.Adjunct Professor Medicine, Boston University在 bu.edu 的電子郵件地址已通過驗證
Max CrispinProfessor of Glycobiology, School of Biological Sciences, University of Southampton在 soton.ac.uk 的電子郵件地址已通過驗證